▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2844 by analyst upside · 2026-06-27
PTCT
PTC Therapeutics, Inc.
Healthcare · Market Cap $7B · P/E 0x
ANALYST PRICE TARGET
+11.3%
implied upside to consensus target
Current Price $84.43
Consensus Target $93.93
Bull Target $124.0
Bear Target $65.0
Analysts Covering 14
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
5
Hold
5
Sell
1
52-Week Low $43.17
52-Week High $87.5
YTD Return +10.0%
FUNDAMENTALS
Market Cap $7B
P/E Ratio (TTM) N/A
Forward P/E 30.3x
EPS (TTM) $-2.54
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $827M
Profit Margin -22.6%
52-WEEK RANGE
52-Week Low $43.17
52-Week High $87.5
Current Price $84.43
Bear Target $65.0
Bull Target $124.0
● Now $84.43 ● Target $93.93
TRADING DATA
Avg Volume 1.5M
YTD Return +10.0%
Analyst Count 14
Consensus Buy
Upside to Target +11.3%
Last Updated 2026-06-27

ANALYST SUMMARY

PTC Therapeutics, Inc. (PTCT) is currently trading at $84.43 with a Wall Street consensus price target of $93.93, implying potential upside of 11.3% over the next 12 months. 14 analysts currently cover PTCT, with a consensus rating of Buy - 57% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $124.0, while the most cautious has a target of $65.0.

PTCT operates in the Healthcare sector with a market capitalisation of $7B. The stock is up 10.0% year-to-date and is currently trading near the upper end of its 52-week range of $43.17 – $87.5.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

QGEN +11.6%
Qiagen N.V.
$8B · P/E 20.1x · Buy
PACS +18.6%
PACS Group, Inc.
$7B · P/E 27.0x · Buy
LNTH -4.2%
Lantheus Holdings, Inc.
$7B · P/E 26.0x · Buy
ATR +27.3%
AptarGroup, Inc.
$8B · P/E 21.6x · Buy
CHE -3.6%
Chemed Corporation
$6B · P/E 24.7x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for PTCT, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Jefferies ↑ Upgrade
Hold → Buy 2026-05-27 50% win rate (6 calls)
TD Cowen ↑ Upgrade
Hold → Buy 2026-05-08 Building track record
RBC Capital — Reiterated
Sector Perform → Sector Perform 2026-05-08 Building track record
Wells Fargo — Reiterated
Overweight → Overweight 2026-05-08 Building track record
Jefferies ↓ Downgrade
Buy → Hold 2026-03-30 50% win rate (6 calls)
Morgan Stanley — Reiterated
Overweight → Overweight 2026-02-23 Building track record
Wells Fargo — Reiterated
Overweight → Overweight 2026-02-20 Building track record
RBC Capital — Reiterated
Sector Perform → Sector Perform 2026-02-20 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
44
out of 100
Coverage depth
21/30
Consensus clarity
16/30
Vote unanimity
5/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →